Veterinary Anti-infectives Market Size Worth USD 15.71 Billion by 2034 | CAGR: 6.3%

The veterinary anti-infectives market size is expected to reach USD 15.71 Billion by 2034, according to a new study by Polaris Market Research. The report “Veterinary Anti-infectives Market Size, Share, Trends, & Industry Analysis Report By Animal Type (Livestock and Companion), By Drug Class, By Route of Administration, By End User, and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The veterinary anti-infectives market is witnessing strong global demand as livestock producers and pet owners seek reliable treatments to manage animal infections. Rising awareness about animal health, food safety, and disease prevention is driving the use of antibiotics, antivirals, antifungals, and antiparasitic products across both farm and companion animals.

Questions? Request a sample or make an inquiry before buying this report by clicking the link below: https://www.polarismarketresearch.com/industry-analysis/veterinary-anti-infectives-market/request-for-sample

Companies in the market are expanding product offerings and investing in new drug delivery systems to improve treatment outcomes and convenience. Advancements in veterinary diagnostics and growing veterinary care infrastructure in emerging regions, are supporting market growth and increasing access to effective animal healthcare solutions.

Veterinary Anti-infectives Market Report Highlights

• Based on animal type, the livestock segment dominated the market in 2024, due to the widespread prevalence of bacterial, viral, and parasitic infections in cattle, poultry, and swine.
• In terms of drug class, the antimicrobial segment dominated the market in 2024. This is owing to the rising adoption of broad-spectrum solutions for treating a wide range of animal diseases across species.
• Based on route of administration, the oral segment dominated the market in 2024, due to ease of administration in livestock production, where medicated feed and water systems allow efficient mass treatment.
• Based on end user, the veterinary hospitals segment held largest market share in 2024, owing to the availability of advanced diagnostic tools, skilled veterinary professionals, and well-developed treatment infrastructure.
• North America accounted for the majority share in the global veterinary anti-infectives market in 2024, attributed to high pet ownership rates and strong demand for companion animal care in the U.S. and Canada.          
• Asia Pacific is expected to grow significantly during the forecast period, owing to improving animal healthcare infrastructure and rising emphasis on food safety and livestock productivity.
• A few global key market players include Biogénesis Bagó S.A., Boehringer Ingelheim GmbH, Calier S.A., Ceva Santé Animale S.A., Dechra Pharmaceuticals Plc., Elanco Animal Health Incorporated, Intervet International B.V. (a subsidiary of Merck & Co., Inc.), Merck & Co., Inc., Norbrook Laboratories Ltd., Phibro Animal Health Corporation, Vetoquinol S.A., Virbac S.A., Zoetis Inc., Bayer AG, Bimeda Animal Health Limited.

Polaris Market Research has segmented the market report on the basis of animal type, drug class, route of administration, end user vertical, and region:

By Animal Type Outlook (Revenue, USD Billion, 2020–2034)

• Livestock
• Companion

By Drug Class Outlook (Revenue, USD Billion, 2020–2034)

• Antimicrobial Agents
• Antiviral Agents
• Antifungal Agents
• Antiparasitic Agents

By Route of Administration Outlook (Revenue, USD Billion, 2020–2034)

• Oral
• Parenteral
• Topical

By End User Vertical Outlook (Revenue, USD Billion, 2020–2034)

• Veterinary Hospitals
• Veterinary Clinics
• Others

By Regional Outlook (Revenue, USD Billion, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America